ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

House Members Form Group To Address Cancer Policy.

February 23, 2001

Groups Urge Congress To Enact NIH Budget Increase; Encourage Individual Letters

November 3, 1995

In Brief: La Jolla Foundation Receives Donated Buildings; Sinks Named Medical Director, Middlesex Hospital

April 27, 1990

Interview with FDA’s Richard Pazdur

October 30, 2009

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

NCI-Approved Trials Listed

March 30, 2007